Latest in Wegovy Zepbound

Sort by

4 items

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance
ABC News - Mar. 5
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Novo Nordisk's weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA.
CNBC - 3d
Hikma races to launch generic versions of blockbuster obesity drugs

Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year
Financial Times - 6d
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
The New York Times - Mar. 5

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly